Skip to content

EUS-HES for hilar biliary obstraction

EUS-HES for hilar biliary obstraction - EUS-HES for hilar biliary obstraction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015420
Enrollment
20
Registered
2015-08-21
Start date
2014-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant hialr biliary obstraction

Interventions

Sponsors

Aichi Cancer Center Hospital
Lead Sponsor
Osaka medical university
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.hilar biliary obstraction 2.high bilirubin level 3.liver dysfunction 4.cholangitis

Exclusion criteria

Exclusion criteria: 1.pregnant 2.easy bleeding 3.short survival 4.massive hilar invasion 5.doctor disagree

Design outcomes

Primary

MeasureTime frame
recovery from OJ, cholangitis, liver dysfunction We evaluate within 14days after the porcedure. Blood test, at tommorrow, 7days, 14days

Countries

Japan

Contacts

Public ContactKazuo Hara

Aichi Cancer Center Hospital gastroenterology

khara@aichi-cc.jp052-732-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026